What should you know about somatostatin immunohistochemistry?

A pathologist applies selected antibodies to thin sections of tissue. If the target is present, a chemical reaction creates a visible stain in the relevant cells. The report may describe whether staining is present, where it appears, and how strong or extensive it is. A positive stain is one feature of a tissue profile; it does not, by itself, name the cancer or prove how it will behave.

Somatostatin staining can be considered alongside the cell pattern, other markers, imaging, symptoms, and blood tests. It is different from a scan that uses a tracer to look for receptors throughout the body. The reason for ordering the stain should be explained in the context of your biopsy.

Request the pathology report and ask which cells stained, what comparison markers were used, and how the finding changes the working diagnosis or treatment discussion. Ask whether more tissue, another stain, or review by a specialist pathologist is needed. Keep the report with your imaging and clinic letters because interpretation depends on the full record.

The stain itself is performed on tissue already collected, so it usually does not create a new physical symptom. Contact your clinical team if you have worsening pain, bleeding, fever, redness, or discharge after the biopsy that supplied the sample. Seek urgent care for severe bleeding, fainting, or breathing difficulty.

Ask why somatostatin was tested, whether the stain is positive or negative, how the result fits with the other markers, and whether it affects further imaging or treatment choices. Ask when the complete pathology interpretation will be available.